<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Med Genet</journal-id><journal-title>BMC Medical Genetics</journal-title><issn pub-type="epub">1471-2350</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-2350-9-119</article-id><article-id pub-id-type="pmid">19115993</article-id><article-id pub-id-type="doi">10.1186/1471-2350-9-119</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Association analyses of the interaction between the <italic>ADSS </italic>and <italic>ATM </italic>genes with schizophrenia in a Chinese population</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Zhang</surname><given-names>Fuquan</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I3">3</xref><email>zhfq@tsinghua.edu.cn</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Xu</surname><given-names>Yong</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>xuyongsmu@yahoo.com.cn</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Liu</surname><given-names>Pozi</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>liupozi@tsinghua.edu.cn</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Fan</surname><given-names>Hua</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>iy4232925@163.com</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Huang</surname><given-names>Xuezhu</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>huangxuezhu@mail.tsinghua.edu.cn</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Sun</surname><given-names>Gaoxiang</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>sunsoartsinghua@hotmail.com</email></contrib><contrib id="A7" contrib-type="author"><name><surname>Song</surname><given-names>Yuqing</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>songyq293@yahoo.com.cn</email></contrib><contrib id="A8" corresp="yes" contrib-type="author"><name><surname>Sham</surname><given-names>Pak C</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>pcsham@hkucc.hku.hk</email></contrib></contrib-group><aff id="I1"><label>1</label>Institute of Neurological disorders, Tsinghua University, Department of Psychiatry, Yuquan Hospital, Tsinghua University, Bejing, 100049, PR China</aff><aff id="I2"><label>2</label>Department of Psychiatry, Beijing Anding Hospital, Capital Medical University, Bejing, PR China</aff><aff id="I3"><label>3</label>Department of Psychiatry, University of Hong Kong, Hong Kong, PR China</aff><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>30</day><month>12</month><year>2008</year></pub-date><volume>9</volume><fpage>119</fpage><lpage>119</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2350/9/119"/><history><date date-type="received"><day>27</day><month>7</month><year>2008</year></date><date date-type="accepted"><day>30</day><month>12</month><year>2008</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2008 Zhang et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2008</copyright-year><copyright-holder>Zhang et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Zhang Fuquan zhfq@tsinghua.edu.cn </dc:author><dc:title> Association analyses of the interaction between the ADSS and ATM genes with schizophrenia in a Chinese population </dc:title><dc:date>2008</dc:date><dcterms:bibliographicCitation>BMC Medical Genetics 9(1): 119-. (2008)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2350(2008)9:1&#x0003c;119&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2350</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>The blood-derived RNA levels of the adenylosuccinate synthase (<italic>ADSS</italic>) and ataxia telangiectasia mutated (<italic>ATM</italic>) genes were found to be down- and up-regulated, respectively, in schizophrenics compared with controls, and <italic>ADSS </italic>and <italic>ATM </italic>were among eight biomarker genes to discriminate schizophrenics from normal controls. ADSS catalyzes the first committed step of AMP synthesis, while ATM kinase serves as a key signal transducer in the DNA double-strand breaks response pathway. It remains unclear whether these changes result from mutations or polymorphisms in the two genes.</p></sec><sec sec-type="methods"><title>Methods</title><p>Six SNPs in the <italic>ADSS </italic>gene and three SNPs in the <italic>ATM </italic>gene in a Chinese population of 488 schizophrenics and 516 controls were genotyped to examine their association with schizophrenia (SZ). Genotyping was performed using the Sequenom platform.</p></sec><sec><title>Results</title><p>There was no significant difference in the genotype, allele, or haplotype distributions of the nine SNPs between cases and controls. Using the Multifactor Dimensionality Reduction (MDR) method, we found that the interactions among rs3102460 in the <italic>ADSS </italic>gene and rs227061 and rs664143 in the <italic>ATM </italic>gene revealed a significant association with SZ. This model held a maximum testing accuracy of 60.4% and a maximum cross-validation consistency of 10 out of 10.</p></sec><sec><title>Conclusion</title><p>These findings suggest that the combined effects of the polymorphisms in the <italic>ADSS </italic>and <italic>ATM </italic>genes may confer susceptibility to the development of SZ in a Chinese population.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Schizophrenia (SZ) is a complex genetic disorder characterized by profound disturbances of cognition, emotion, and social functioning. Numerous family, twin, and adoption studies conclusively show that SZ risk is increased among the relatives of affected individuals and that SZ is largely the result of genes rather than shared environment [<xref ref-type="bibr" rid="B1">1</xref>], the estimated heritability of SZ is 80&#x02013;85% [<xref ref-type="bibr" rid="B2">2</xref>]. Besides traditional association or linkage studies, recent advances have facilitated the use of circulating blood to conduct genomic analyses of human diseases [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>]; the search for the genetic basis of SZ has produced some lines of evidence at the level of gene expression. By analyzing the blood-derived RNA from 74 samples, linear and nonlinear combinations of eight putative biomarker genes (<italic>APOBEC3B, ADSS, ATM, CLC, CTBP1, DATF1, CXCL1</italic>, and <italic>S100A9</italic>) were able to discriminate between SZ, bipolar disorder, and control samples [<xref ref-type="bibr" rid="B5">5</xref>], with an overall accuracy of 95 &#x02013; 97%. As yet, none of these genes have been investigated for their association or linkage disequilibrium (LD) with SZ.</p><p>It has been shown that adenylosuccinate synthase (<italic>ADSS</italic>) is downregulated, while ataxia telangiectasia mutated (<italic>ATM</italic>) is upregulated, in schizophrenics [<xref ref-type="bibr" rid="B5">5</xref>]. The de novo biosynthesis of AMP from IMP involves two steps: the first step is catalyzed by ADSS, and the second step is catalyzed by adenylosuccinate lyase [<xref ref-type="bibr" rid="B6">6</xref>]. <italic>ADSS </italic>can influence energy metabolism through the purine nucleotide cycle and the AMP-activated protein kinase (AMPK) pathway [<xref ref-type="bibr" rid="B7">7</xref>]. Cyclic AMP (cAMP), a very close structural relative of AMP, containing an additional ester linkage between the phosphate and ribose units, acts as a secondary messenger for several hormones. It is tempting to postulate that <italic>ADSS </italic>may play a role in the pathogenesis of the illness via energy metabolism or nucleotide synthesis.</p><p>DNA damage poses a continuous threat to genomic integrity in mammalian cells, with the most deleterious form being double-strand breaks (DSBs). ATM signaling is required to sense and initiate repair of DSBs. When DSBs occur, ATM initiates a well-characterized response to DNA damage, resulting in cell-cycle arrest, DNA repair, or apoptosis. In this way, ATM functions as a fundamental safeguard against genomic instability during organism development. ATM and ATR (ATM and Rad3-related) substrate analysis revealed extensive protein networks responsive to DNA damage, involving more than 900 regulated phosphorylation sites encompassing over 700 proteins [<xref ref-type="bibr" rid="B8">8</xref>]. Thus ATM may be a possible candidate gene underlying SZ.</p><p>cAMP response element binding protein is phosphorylated by ATM on Ser-121 in response to ionizing radiation and oxidative stress [<xref ref-type="bibr" rid="B9">9</xref>]. ATM has been shown to phosphorylate the AMPK &#x003b1; subunit [<xref ref-type="bibr" rid="B10">10</xref>], and ATM-dependent mitochondrial biogenesis is mediated through AMPK [<xref ref-type="bibr" rid="B11">11</xref>]. These studies provide evidence of their interaction in some pathways possibly affecting brain function. Therefore, we hypothesized that there may be interactions between these two genes conferring disease risk for SZ, but it is unknown whether genetic variation underlies the alterations in <italic>ADSS </italic>and <italic>ATM </italic>expression. To test the hypothesis that sequence variations in the <italic>ADSS </italic>or <italic>ATM </italic>genes influence risk for the disease, we conducted a case-control association study on nine SNPs within the two genes in a Chinese Han population. Frequency of alleles, genotypes, and haplotypes of the nine SNPs were tested between cases and controls.</p><p>Because SZ is a common disease with a complex multifactorial etiology, several recent approaches are promising for detecting gene-gene and gene-environment interactions. Multifactor Dimensionality Reduction (MDR) is a data reduction method for detecting multilocus genotype combinations that predict disease risk for common, complex disease [<xref ref-type="bibr" rid="B12">12</xref>-<xref ref-type="bibr" rid="B14">14</xref>]. MDR pools genotypes into "high risk" and "low risk" groups to reduce multidimensional data into only one dimension. A certain threshold, defined as the ratio of cases to controls, determines the risk group to which a factor combination is assigned [<xref ref-type="bibr" rid="B15">15</xref>]. Using MDR, many studies have observed that complex interactions among multiple genes may make a genetic contribution to complex disorders [<xref ref-type="bibr" rid="B16">16</xref>-<xref ref-type="bibr" rid="B18">18</xref>], including SZ [<xref ref-type="bibr" rid="B19">19</xref>-<xref ref-type="bibr" rid="B21">21</xref>]. Here, we explored the epistasis, or gene &#x000d7; gene interaction, between the two genes via MDR.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Subjects</title><p>A total sample of 488 unrelated SZ patients and 516 healthy controls was collected. Cases were recruited from Hong Kong hospitals. All patients were interviewed using the Structured Clinical Interview for DSM-IV and met the DSM-IV diagnostic criteria for SZ.</p><p>Healthy controls were recruited from blood donors who were not screened for psychiatric diseases; however, in Hong Kong an individual would be ineligible for blood donation if he is under a doctor's care, taking medications, awaiting test results, or suffering from any serious illness. All subjects were Han Chinese. Peripheral blood sample were obtained from the subjects. The present study was approved by the Institutional Review Board of the University of Hong Kong/Hospital Authority Hong Kong West Cluster, and written informed consent was obtained from all subjects.</p></sec><sec><title>Genotyping</title><p>Based on the location and the heterozygosity of the SNPs, we selected six SNPs (rs3102460, rs3127459, rs3127460, rs3127465, rs3006001, and rs3003211) in the <italic>ADSS </italic>gene and three SNPs (rs600931, rs227061, and rs664143) in the <italic>ATM </italic>gene to check their allelic and haplotypic association to SZ in a case-control sample.</p><p>We used a Sequenom platform (Sequenom MassARRAY System, Sequenom, San Diego, CA, USA) for assay design and genotyping. SNP sites were amplified by PCR in multiplex format in 384-well microtiter plates by a pair of specifically designed forward and reverse PCR primers. The length of the amplicons for the SNP capture ranged from 60 to 120 base pairs. Following genomic amplification of the target regions, PCR products were treated with shrimp alkaline phosphatase for 20 min at 37&#x000b0;C to dephosphorylate any residual nucleotides and to prevent their future incorporation and interference with the primer extension assay. Extension primers, DNA polymerase, and a cocktail mixture of deoxynucleotides and dideoxynucleotide triphosphates were added to each mix. These were then followed by cycles of homogeneous MassEXTEND reaction probed by the extension primers for each SNP. The MassARRAY typer software (version 3.1) was then used to read out the extended mass and assign the genotype call. Quality control criteria included a genotype call rate of &#x0003e; 80%, less than 1 duplicate error (5 duplicates in each 96-well plate), and significant Hardy-Weinberg disequilibrium.</p></sec><sec><title>Statistical analyses</title><p>Hardy-Weinberg equilibrium and genotype and allele frequencies between cases and controls were tested using PLINK-1.05 [<xref ref-type="bibr" rid="B22">22</xref>]. LD between markers was tested with Haploview version 4.1 (Barrett, 2005). Haplotype analyses were performed using UNPHASED (version 3.0.5) [<xref ref-type="bibr" rid="B23">23</xref>], as well as SHEsis [<xref ref-type="bibr" rid="B24">24</xref>]. Haplotypes with frequencies &#x0003c; 3% in the whole sample were considered to be rare and were excluded. The gene-gene interactions were analyzed by MDR. Ten-fold cross-validation was used in our MDR analysis. Data were randomly split into 10 approximately equal parts; one subdivision was used as the testing set and the rest as the training set. In view of our data, we considered two- to four-locus interaction models, performing 1,000 permutations.</p></sec></sec><sec><title>Results</title><sec><title>Genotype and allele distributions of SNPs</title><p>The distributions of allele and genotype frequencies of nine SNPs among 488 SZ patients and 516 healthy controls are shown in Table <xref ref-type="table" rid="T1">1</xref>. The genotypic distributions of these nine polymorphisms do not deviate significantly from Hardy-Weinberg equilibrium in both patients and controls (data not shown). There was no significant difference in genotype or allele frequencies between cases and controls.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Genotypic and allelic distributions of the 9 SNPs in cases and controls</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center">SNP</td><td></td><td align="left" colspan="3">Genotype Frequency (%) p(df = 2)</td><td align="left" colspan="2">Allele Frequency (%) p(df = 1) OR(95%CI)</td></tr></thead><tbody><tr><td></td><td></td><td align="left">CC</td><td align="left">CT</td><td align="left">TT</td><td align="left">C</td><td align="left">T</td></tr><tr><td align="center">SNP1:rs3102460</td><td align="center">ca 441</td><td align="left" colspan="3">48(10.9) 176(39.9) 217(49.2) 0.435</td><td align="left" colspan="2">272(30.8) 610(69.2) 0.329 1.10(0.90&#x02013;1.35)</td></tr><tr><td></td><td align="center">co 444</td><td align="left" colspan="3">37(8.3) 181(40.8) 226(50.9)</td><td align="left" colspan="2">255(28.7) 633(71.3)</td></tr><tr><td></td><td></td><td align="left">AA</td><td align="left">AT</td><td align="left">TT</td><td align="left">A</td><td align="left">T</td></tr><tr><td align="center">SNP2:rs3127459</td><td align="center">ca 481</td><td align="left" colspan="3">26(5.4) 172(35.8) 283(58.8) 0.404</td><td align="left" colspan="2">224(23.3) 738(76.7) 0.214 0.88(0.71&#x02013;1.08)</td></tr><tr><td></td><td align="center">co 508</td><td align="left" colspan="3">37(7.3) 187(36.8) 284(55.9)</td><td align="left" colspan="2">261(25.7) 755(74.3)</td></tr><tr><td></td><td></td><td align="left">TT</td><td align="left">AT</td><td align="left">AA</td><td align="left">T</td><td align="left">A</td></tr><tr><td align="center">SNP3:rs3127460</td><td align="center">ca 482</td><td align="left" colspan="3">12(2.5) 151(31.3) 319(66.2) 0.720</td><td align="left" colspan="2">175(18.2) 789(81.8) 0.463 0.92(0.74&#x02013;1.16)</td></tr><tr><td></td><td align="center">co 504</td><td align="left" colspan="3">16(3.2) 164(32.5) 324(64.3)</td><td align="left" colspan="2">196(19.4) 812(80.6)</td></tr><tr><td></td><td></td><td align="left">CC</td><td align="left">CT</td><td align="left">TT</td><td align="left">C</td><td align="left">T</td></tr><tr><td align="center">SNP4: rs3127465</td><td align="center">ca 474</td><td align="left" colspan="3">11(2.3) 144(30.4) 319(67.3) 0.697</td><td align="left" colspan="2">166(17.5) 782(82.5) 0.595 0.93(0.74&#x02013;1.18)</td></tr><tr><td></td><td align="center">co 499</td><td align="left" colspan="3">16(3.2) 152(30.5) 331(66.3)</td><td align="left" colspan="2">184(18.4) 814(81.6)</td></tr><tr><td></td><td></td><td align="left">CC</td><td align="left">AC</td><td align="left">AA</td><td align="left">C</td><td align="left">A</td></tr><tr><td align="center">SNP5: rs3006001</td><td align="center">ca 481</td><td align="left" colspan="3">12(2.5) 148(30.8) 321(66.7) 0.636</td><td align="left" colspan="2">172(17.9) 790(82.1) 0.362 0.91(0.72&#x02013;1.14)</td></tr><tr><td></td><td align="center">co 503</td><td align="left" colspan="3">16(3.2) 164(32.6) 323(64.2)</td><td align="left" colspan="2">196(19.5) 810(80.5)</td></tr><tr><td></td><td></td><td align="left">GG</td><td align="left">AG</td><td align="left">AA</td><td align="left">G</td><td align="left">A</td></tr><tr><td align="center">SNP6: rs3003211</td><td align="center">ca 436</td><td align="left" colspan="3">50(11.5) 171(39.2) 215(49.3) 0.724</td><td align="left" colspan="2">271(31.1) 601(68.9) 0.455 1.09(0.89&#x02013;1.34)</td></tr><tr><td></td><td align="center">co 455</td><td align="left" colspan="3">45(9.9) 178(39.1) 232(51)</td><td align="left" colspan="2">268(29.5) 642(70.5)</td></tr><tr><td></td><td></td><td align="left">AA</td><td align="left">AG</td><td align="left">GG</td><td align="left">A</td><td align="left">G</td></tr><tr><td align="center">SNP7: rs600931</td><td align="center">ca 479</td><td align="left" colspan="3">82(17.1) 231(48.2) 166(34.7) 0.556</td><td align="left" colspan="2">395(41.2) 563(58.8) 0.462 1.06(0.89&#x02013;1.28)</td></tr><tr><td></td><td align="center">co 500</td><td align="left" colspan="3">73(14.6) 250(50) 177(35.4)</td><td align="left" colspan="2">396(39.6) 604(60.4)</td></tr><tr><td></td><td></td><td align="left">GG</td><td align="left">AG</td><td align="left">AA</td><td align="left">G</td><td align="left">A</td></tr><tr><td align="center">SNP8: rs227061</td><td align="center">ca 481</td><td align="left" colspan="3">82(17.0) 231(48) 168(34.9) 0.496</td><td align="left" colspan="2">395(41.1) 567(58.9) 0.465 0.94(0.78&#x02013;1.13)</td></tr><tr><td></td><td align="center">co 502</td><td align="left" colspan="3">72(14.3) 252(50.2) 178(35.5)</td><td align="left" colspan="2">396(39.4) 608(60.6)</td></tr><tr><td></td><td></td><td align="left">CC</td><td align="left">CT</td><td align="left">TT</td><td align="left">C</td><td align="left">T</td></tr><tr><td align="center">SNP9: rs664143</td><td align="center">ca 483</td><td align="left" colspan="3">92(19.0) 227(47) 164(34) 0.163</td><td align="left" colspan="2">411(42.5) 555(57.5) 0.950 1.01(0.84&#x02013;1.20)</td></tr><tr><td></td><td align="center">co 507</td><td align="left" colspan="3">81(16.0) 268(52.9) 158(31.2)</td><td align="left" colspan="2">430(42.4) 584(57.6)</td></tr></tbody></table><table-wrap-foot><p>ca = case; co = control.</p></table-wrap-foot></table-wrap></sec><sec><title>Patterns of LD</title><p>The patterns of pairwise LD between neighboring SNPs are shown in Table <xref ref-type="table" rid="T2">2</xref>. D primes range from approximately 0.96 to 1. Fairly tight LD was observed in any pair of the 1&#x02013;6 SNPs in <italic>ADSS </italic>and the 7&#x02013;9 SNPs in <italic>ATM</italic>, and SNPs of each gene were in strong LD.</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Pairwise linkage disequilibrium (LD) of the SNPs within each gene</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">D'</td><td align="right">SNP2</td><td align="right">SNP3</td><td align="right">SNP4</td><td align="right">SNP5</td><td align="right">SNP6</td><td align="right">SNP8</td><td align="right">SNP9</td></tr></thead><tbody><tr><td align="left">SNP1</td><td align="right">0.99</td><td align="right">0.96</td><td align="right">1</td><td align="right">0.98</td><td align="right">0.99</td><td></td><td></td></tr><tr><td align="left">SNP2</td><td></td><td align="right">0.98</td><td align="right">0.99</td><td align="right">0.99</td><td align="right">0.99</td><td></td><td></td></tr><tr><td align="left">SNP3</td><td></td><td></td><td align="right">0.99</td><td align="right">0.99</td><td align="right">0.96</td><td></td><td></td></tr><tr><td align="left">SNP4</td><td></td><td></td><td></td><td align="right">1</td><td align="right">1</td><td></td><td></td></tr><tr><td align="left">SNP5</td><td></td><td></td><td></td><td></td><td align="right">0.98</td><td></td><td></td></tr><tr><td align="left">SNP7</td><td></td><td></td><td></td><td></td><td></td><td align="right">0.99</td><td align="right">1</td></tr><tr><td align="left">SNP8</td><td></td><td></td><td></td><td></td><td></td><td></td><td align="right">0.99</td></tr></tbody></table></table-wrap></sec><sec><title>Haplotypes of the SNPs in ADSS and ATM</title><p>There was no individual or global significant difference for the 6-marker haplotypes in <italic>ADSS </italic>or the 3-marker haplotypes in <italic>ATM </italic>between cases and controls (Table <xref ref-type="table" rid="T3">3</xref>). Individual haplotype tests were performed by evaluating the risk difference between a specific haplotype and all others grouped together.</p><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Estimated haplotype frequencies and association significance of <italic>ADSS </italic>and <italic>ATM</italic></p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center">Gene</td><td align="center">SNP</td><td align="center">Haplotype</td><td align="center">Case (freq%) Control (freq%)</td><td align="center">X<sup>2 </sup>p</td><td align="center">OR (95%CI)</td><td align="center">Global p</td></tr></thead><tbody><tr><td align="center">ADSS</td><td align="center">SNP1-SNP6</td><td align="center">TTATAA</td><td align="center">372.0(46.2) 364.6(45)</td><td align="center">0.119 0.731</td><td align="center">1.04 (0.85&#x02013;1.26)</td><td align="center">0.339</td></tr><tr><td></td><td></td><td align="center">CTATAG</td><td align="center">243.0(30.1) 221.4(27.3)</td><td align="center">1.388 0.239</td><td align="center">1.14 (0.92&#x02013;1.41)</td><td></td></tr><tr><td></td><td></td><td align="center">TATCCA</td><td align="center">140.0(17.4) 156.0(19.3)</td><td align="center">1.087 0.297</td><td align="center">0.87 (0.68&#x02013;1.13)</td><td></td></tr><tr><td></td><td></td><td align="center">TAATAA</td><td align="center">45.0(5.6) 57.0(7.0)</td><td align="center">1.523 0.217</td><td align="center">0.78 (0.52&#x02013;1.16)</td><td></td></tr><tr><td align="center">ATM</td><td align="center">SNP7-SNP9</td><td align="center">A G C</td><td align="center">384.0(40.8) 377.0(39.3)</td><td align="center">0.254 0.613</td><td align="center">1.05 (0.87&#x02013;1.26)</td><td align="center">0.600</td></tr><tr><td></td><td></td><td align="center">G A T</td><td align="center">538.0(57.1) 554.0(57.7)</td><td align="center">0.254 0.615</td><td align="center">0.95 (0.79&#x02013;1.15)</td><td></td></tr></tbody></table><table-wrap-foot><p>Freq = frequency. Haplotypes were omitted from analysis if the estimated haplotype probabilities were less than 3%</p></table-wrap-foot></table-wrap></sec><sec><title>Gene-gene interactions among ADSS and ATM</title><p>Gene-gene interactions of the nine SNPs were examined using the MDR method, and the results for each number of factors considered are summarized in Table <xref ref-type="table" rid="T4">4</xref>. We tested 2- to 4-locus combinations within the two genes. Because the MDR procedure works best with the model that has the maximum cross-validation consistency and minimum prediction error, the three locus model, involving rs3102460 in the <italic>ADSS </italic>gene as well as rs227061 and rs664143 in the <italic>ATM </italic>gene, had a cross-validation consistency of 10, being regarded as the best (<italic>p </italic>= 0.011). The 1000-fold permutations test showed that <italic>p </italic>was larger than 0.05 (Figure <xref ref-type="fig" rid="F1">1</xref>).</p><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>The interaction models detected by MDR</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">model</td><td align="right">training bal. acc.</td><td align="right">testing bal. acc.</td><td align="left">Sign test (p)</td><td align="left">CV consistency</td></tr></thead><tbody><tr><td align="left">SNP 9</td><td align="right">0.5307</td><td align="right">0.5307</td><td align="left">7 (0.172)</td><td align="left">10/10</td></tr><tr><td align="left">SNP 1, 9</td><td align="right">0.5476</td><td align="right">0.4989</td><td align="left">3 (0.945)</td><td align="left">7/10</td></tr><tr><td align="left">SNP 1, 8, 9</td><td align="right">0.5593</td><td align="right">0.5260</td><td align="left">9 (0.011)*</td><td align="left">10/10</td></tr><tr><td align="left">SNP 1, 7, 8, 9</td><td align="right">0.5638</td><td align="right">0.5199</td><td align="left">8 (0.055)</td><td align="left">10/10</td></tr></tbody></table><table-wrap-foot><p>bal. acc.: Balanced Accuracy. *: p &#x0003e; 0.05 based on 1000 permutations</p></table-wrap-foot></table-wrap><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>The best three-locus SNP model selected by MDR</bold>. 0, homozygote of common allele; 1, heterozygote; 2, homozygote of rare allele. High risk combinations are depicted as dark-shaded cells; low-risk combinations are depicted as light-shaded cells; empty cells are left blank. For each cell, the left bar indicates the total number of cases, and the right bar indicates the total number of controls.</p></caption><graphic xlink:href="1471-2350-9-119-1"/></fig></sec></sec><sec><title>Discussion</title><p>Besides several very promising candidate genes for SZ, such as <italic>NRG1 </italic>[<xref ref-type="bibr" rid="B25">25</xref>], <italic>DTNBP1 </italic>[<xref ref-type="bibr" rid="B26">26</xref>], <italic>COMT </italic>[<xref ref-type="bibr" rid="B27">27</xref>], <italic>DISC1 </italic>[<xref ref-type="bibr" rid="B28">28</xref>], and <italic>DAOA </italic>[<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B30">30</xref>], there may also be genes that play subtle or weak roles in the pathogenesis of SZ, making them difficult to identify by traditional approaches. An alternative approach is the use of microarray technology to examine differential RNA gene expression between patients and controls, by which <italic>ADSS </italic>and <italic>ATM </italic>were suggested as biomarker genes for SZ [<xref ref-type="bibr" rid="B5">5</xref>]. Although the mechanism underlying the alterations is unknown, the results suggest that the <italic>ADSS </italic>and <italic>ATM </italic>genes may be involved in the genetic architecture of SZ, since genetic polymorphisms within the genes may influence gene expression.</p><p>The gene encoding <italic>ADSS </italic>maps to 1cen-q12, a chromosomal locus previously linked to SZ by meta-analysis [<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B32">32</xref>]. Similarly, <italic>ATM</italic>'s genomic location, 11q22&#x02013;23, was reported to be one of the genetic susceptibility regions by meta-analysis [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B32">32</xref>-<xref ref-type="bibr" rid="B36">36</xref>] and several other independent studies [<xref ref-type="bibr" rid="B33">33</xref>-<xref ref-type="bibr" rid="B36">36</xref>]. This region also contains another controversial risk gene, <italic>DRD2 </italic>(dopamine receptor D2) [<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B38">38</xref>].</p><p>The <italic>ADSS </italic>gene is 44 kb in length with 13 exons. Six SNPs from intron 11 (rs3102460), intron 6 (rs3127459), intron 4 (rs3127460), and intron 1 (rs3127465, rs3006001, and rs3003211) in the <italic>ADSS </italic>gene were selected for the current study. Among them, rs3102460, rs3127465, and rs3006001 were predicted to influence transcriptional regulation; no functional information exists for the remaining three SNPs yet [<xref ref-type="bibr" rid="B39">39</xref>]. The <italic>ATM </italic>gene is 146 kb in length, consisting of 63 exons. The three SNPs in <italic>ATM </italic>are from intron 7 (rs600931), intron 54 (rs227061), and intron 61 (rs664143); rs227061 and rs664143 possibly affect transcriptional regulation [<xref ref-type="bibr" rid="B39">39</xref>]. Our data did not yield any statistically significant difference for genotype, allele, or haplotype distributions between cases and controls.</p><p>Epistasis, or gene &#x000d7; gene interaction, is increasingly assumed to play a crucial role in the genotype-to-phenotype relationship of common diseases [<xref ref-type="bibr" rid="B40">40</xref>]. Although the ubiquity of joint actions appears to be a natural property of complex traits, the nature of joint actions has not been well investigated or understood. To our knowledge, this is the first genetic study to test the joint action of the <italic>ADSS </italic>and <italic>ATM </italic>genes in relation to SZ. The interactions between <italic>ADSS </italic>and <italic>ATM </italic>were assessed using the MDR program, which has been widely used for detecting epistasis in complex human diseases. The combined effects of the polymorphisms in <italic>GRIN1 </italic>and <italic>GRIN2B </italic>[<xref ref-type="bibr" rid="B19">19</xref>], as well as the combined effects of <italic>GAD1</italic>, <italic>GAD2</italic>, and <italic>GABRB2 </italic>[<xref ref-type="bibr" rid="B21">21</xref>], were found to be associated with SZ in a Chinese population. Yasuno etc. [<xref ref-type="bibr" rid="B20">20</xref>] suggested that synergistic interaction between <italic>UCP </italic>(uncoupling protein) 2 and <italic>UCP4 </italic>may be involved in the etiology of SZ in a Japanese population. In our analysis, the three-locus model (rs3102460 in the <italic>ADSS </italic>gene and rs227061 and rs664143 in the <italic>ATM </italic>gene) was selected as the best one for determining SZ susceptibility based on its balanced accuracy and cross-validation consistency, which suggests that the interactions among these SNPs may be associated with SZ. An interaction dendrogram from the MDR demonstrated a strong synergic interaction between SNP1 and SNP8, suggesting a combined effect between the two genes; however, the result was not robust enough to survive correction of permutation test, indicating the need for larger samples to validate our result. Nevertheless, based on the cross-validation consistency and testing accuracy, the results could partially support the hypothesis that some loci contribute to a certain complex disease only through interaction with other genes (epistasis), while the main effects of the individual locus may be small or absent [<xref ref-type="bibr" rid="B41">41</xref>]. Detection of an interaction between the two genes is potentially novel and intriguing from a biological perspective because it suggests the attractive implication that an impediment of DNA repair may play a role in the abnormal neurodevelopment in SZ. Such predictions deserve to be validated experimentally using systems biology approaches and animal models.</p><p>This study sought to explore the genetic basis of SZ using clues from RNA alteration. Although it did not support <italic>ADSS </italic>or <italic>ATM </italic>as an individual candidate gene for the illness, the study suggested that the epistatic effect of a three-locus interaction within the <italic>ADSS </italic>and <italic>ATM </italic>genes may exist for SZ susceptibility. One common issue in the study of complex diseases is the limited sample size, resulting in inadequate power to detect association. Assuming the frequency of risk allele in controls to be 0.5, our sample of 488 cases and 516 controls is able to detect an odds ratio of 1.37 or above with 80% power [<xref ref-type="bibr" rid="B42">42</xref>]. With regard to our data, the absence of main effects of polymorphisms in <italic>ADSS </italic>or <italic>ATM </italic>may arise from insufficient power. Similarly, Qin etc. [<xref ref-type="bibr" rid="B19">19</xref>] detected interactions between the <italic>GRIN1 </italic>and <italic>GRIN2B </italic>genes in the absence of main effects of a single marker in SZ.</p><p>Case-control studies are susceptible to positive and negative artifacts from unknown population stratifications or different levels of ethnic admixture among cases and controls. Family-based association studies are helpful to circumvent stratification biases, so it is necessary to examine the transmission from parents to affected offspring in future studies. Moreover, because different populations have distinct genetic backgrounds, it is necessary to validate or replicate our association results using independent samples, especially from other ethnic populations. Our data should be interpreted with caution, considering it was a statistical epistasis. Therefore, experiments demonstrating the mechanisms by which alterations in these two genes in tandem can cause brain and behavioral changes associated with SZ would provide the most vital support for our hypothesis.</p></sec><sec><title>Conclusion</title><p>In spite of potential limitations, the results of our study show that the combined actions of the polymorphisms in the <italic>ADSS </italic>and <italic>ATM </italic>genes may confer a risk for the development of SZ in a Chinese population. Larger sample studies involving more SNPs within the two genes, as well as neurobiological experiments implicating their role in SZ, are needed to validate our results.</p></sec><sec><title>Abbreviations</title><p>APOBEC3B: apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B; CLC: Charcot-Leyden crystal protein; COMT: catechol-O-methyltransferase; CTBP1: C-terminal binding protein 1; CXCL1: chemokine (C-X-C motif) ligand 1; DAOA: D-amino acid oxidase activator; DIDO1: death inducer-obliterator 1; DISC1: disrupted in schizophrenia 1; DTNBP1: dystrobrevin binding protein 1; NRG1: neuregulin 1; S100A9: S100 calcium binding protein A9.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>SP designed and supervised the study. ZF, XY and LP drafted the manuscript. FH, SY, SG and HX participate in data analysis. All authors read and approved the final manuscript.</p></sec><sec><title>Pre-publication history</title><p>The pre-publication history for this paper can be accessed here:</p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2350/9/119/prepub"/></p></sec></body><back><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kirov</surname><given-names>G</given-names></name><name><surname>O'Donovan</surname><given-names>MC</given-names></name><name><surname>Owen</surname><given-names>MJ</given-names></name></person-group><article-title>Finding schizophrenia genes</article-title><source>J Clin Invest</source><year>2005</year><volume>115</volume><fpage>1440</fpage><lpage>1448</lpage><pub-id pub-id-type="pmid">15931379</pub-id><pub-id pub-id-type="doi">10.1172/JCI24759</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cardno</surname><given-names>AG</given-names></name><name><surname>Gottesman</surname><given-names>II</given-names></name></person-group><article-title>Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics</article-title><source>Am J Med Genet</source><year>2000</year><volume>97</volume><fpage>12</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">10813800</pub-id><pub-id pub-id-type="doi">10.1002/(SICI)1096-8628(200021)97:1&#x0003c;12::AID-AJMG3&#x0003e;3.0.CO;2-U</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nishimura</surname><given-names>Y</given-names></name><name><surname>Martin</surname><given-names>CL</given-names></name><name><surname>Vazquez-Lopez</surname><given-names>A</given-names></name><name><surname>Spence</surname><given-names>SJ</given-names></name><name><surname>Alvarez-Retuerto</surname><given-names>AI</given-names></name><name><surname>Sigman</surname><given-names>M</given-names></name><name><surname>Steindler</surname><given-names>C</given-names></name><name><surname>Pellegrini</surname><given-names>S</given-names></name><name><surname>Schanen</surname><given-names>NC</given-names></name><name><surname>Warren</surname><given-names>ST</given-names></name><name><surname>Geschwind</surname><given-names>DH</given-names></name></person-group><article-title>Genome-wide expression profiling of lymphoblastoid cell lines distinguishes different forms of autism and reveals shared pathways</article-title><source>Hum Mol Genet</source><year>2007</year><volume>16</volume><fpage>1682</fpage><lpage>1698</lpage><pub-id pub-id-type="pmid">17519220</pub-id><pub-id pub-id-type="doi">10.1093/hmg/ddm116</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vahteristo</surname><given-names>P</given-names></name><name><surname>Kokko</surname><given-names>A</given-names></name><name><surname>Saksela</surname><given-names>O</given-names></name><name><surname>Aittomaki</surname><given-names>K</given-names></name><name><surname>Aaltonen</surname><given-names>LA</given-names></name></person-group><article-title>Blood-derived gene-expression profiling in unravelling susceptibility to recessive disease</article-title><source>J Med Genet</source><year>2007</year><volume>44</volume><fpage>718</fpage><lpage>720</lpage><pub-id pub-id-type="pmid">17660462</pub-id><pub-id pub-id-type="doi">10.1136/jmg.2007.051342</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsuang</surname><given-names>MT</given-names></name><name><surname>Nossova</surname><given-names>N</given-names></name><name><surname>Yager</surname><given-names>T</given-names></name><name><surname>Tsuang</surname><given-names>MM</given-names></name><name><surname>Guo</surname><given-names>SC</given-names></name><name><surname>Shyu</surname><given-names>KG</given-names></name><name><surname>Glatt</surname><given-names>SJ</given-names></name><name><surname>Liew</surname><given-names>CC</given-names></name></person-group><article-title>Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: a preliminary report</article-title><source>Am J Med Genet B Neuropsychiatr Genet</source><year>2005</year><volume>133B</volume><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">15645418</pub-id><pub-id pub-id-type="doi">10.1002/ajmg.b.30161</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mehrotra</surname><given-names>S</given-names></name><name><surname>Balaram</surname><given-names>H</given-names></name></person-group><article-title>Kinetic characterization of adenylosuccinate synthetase from the thermophilic archaea Methanocaldococcus jannaschii</article-title><source>Biochemistry-Us</source><year>2007</year><volume>46</volume><fpage>12821</fpage><lpage>12832</lpage><pub-id pub-id-type="doi">10.1021/bi701009y</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Zhu</surname><given-names>Z</given-names></name><name><surname>Mo</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>K</given-names></name></person-group><article-title>Comparative molecular characterization of ADSS1 and ADSS2 genes in pig (Sus scrofa)</article-title><source>Comp Biochem Physiol B Biochem Mol Biol</source><year>2007</year><volume>147</volume><fpage>271</fpage><lpage>277</lpage><pub-id pub-id-type="pmid">17347008</pub-id><pub-id pub-id-type="doi">10.1016/j.cbpb.2007.01.013</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsuoka</surname><given-names>S</given-names></name><name><surname>Ballif</surname><given-names>BA</given-names></name><name><surname>Smogorzewska</surname><given-names>A</given-names></name><name><surname>McDonald</surname><given-names>ER</given-names></name><name><surname>Hurov</surname><given-names>KE</given-names></name><name><surname>Luo</surname><given-names>J</given-names></name><name><surname>Bakalarski</surname><given-names>CE</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Solimini</surname><given-names>N</given-names></name><name><surname>Lerenthal</surname><given-names>Y</given-names></name><name><surname>Shiloh</surname><given-names>Y</given-names></name><name><surname>Gygi</surname><given-names>SP</given-names></name><name><surname>Elledge</surname><given-names>SJ</given-names></name></person-group><article-title>ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage</article-title><source>Science</source><year>2007</year><volume>316</volume><fpage>1160</fpage><lpage>1166</lpage><pub-id pub-id-type="pmid">17525332</pub-id><pub-id pub-id-type="doi">10.1126/science.1140321</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dodson</surname><given-names>GE</given-names></name><name><surname>Tibbetts</surname><given-names>RS</given-names></name></person-group><article-title>DNA replication stress-induced phosphorylation of cyclic AMP response element-binding protein mediated by ATM</article-title><source>J Biol Chem</source><year>2006</year><volume>281</volume><fpage>1692</fpage><lpage>1697</lpage><pub-id pub-id-type="pmid">16293623</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M509577200</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>A</given-names></name><name><surname>Kusakai</surname><given-names>G</given-names></name><name><surname>Kishimoto</surname><given-names>A</given-names></name><name><surname>Shimojo</surname><given-names>Y</given-names></name><name><surname>Ogura</surname><given-names>T</given-names></name><name><surname>Lavin</surname><given-names>MF</given-names></name><name><surname>Esumi</surname><given-names>H</given-names></name></person-group><article-title>IGF-1 phosphorylates AMPK-alpha subunit in ATM-dependent and LKB1-independent manner</article-title><source>Biochem Biophys Res Commun</source><year>2004</year><volume>324</volume><fpage>986</fpage><lpage>992</lpage><pub-id pub-id-type="pmid">15485651</pub-id><pub-id pub-id-type="doi">10.1016/j.bbrc.2004.09.145</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>X</given-names></name><name><surname>Wan</surname><given-names>S</given-names></name><name><surname>Lyu</surname><given-names>YL</given-names></name><name><surname>Liu</surname><given-names>LF</given-names></name><name><surname>Qi</surname><given-names>H</given-names></name></person-group><article-title>Etoposide induces ATM-dependent mitochondrial biogenesis through AMPK activation</article-title><source>PLoS ONE</source><year>2008</year><volume>3</volume><fpage>e2009</fpage><pub-id pub-id-type="pmid">18431490</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0002009</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hahn</surname><given-names>LW</given-names></name><name><surname>Ritchie</surname><given-names>MD</given-names></name><name><surname>Moore</surname><given-names>JH</given-names></name></person-group><article-title>Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions</article-title><source>Bioinformatics</source><year>2003</year><volume>19</volume><fpage>376</fpage><lpage>382</lpage><pub-id pub-id-type="pmid">12584123</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/btf869</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Motsinger</surname><given-names>AA</given-names></name><name><surname>Ritchie</surname><given-names>MD</given-names></name></person-group><article-title>Multifactor dimensionality reduction: an analysis strategy for modelling and detecting gene-gene interactions in human genetics and pharmacogenomics studies</article-title><source>Hum Genomics</source><year>2006</year><volume>2</volume><fpage>318</fpage><lpage>328</lpage><pub-id pub-id-type="pmid">16595076</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ritchie</surname><given-names>MD</given-names></name><name><surname>Hahn</surname><given-names>LW</given-names></name><name><surname>Roodi</surname><given-names>N</given-names></name><name><surname>Bailey</surname><given-names>LR</given-names></name><name><surname>Dupont</surname><given-names>WD</given-names></name><name><surname>Parl</surname><given-names>FF</given-names></name><name><surname>Moore</surname><given-names>JH</given-names></name></person-group><article-title>Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer</article-title><source>Am J Hum Genet</source><year>2001</year><volume>69</volume><fpage>138</fpage><lpage>147</lpage><pub-id pub-id-type="pmid">11404819</pub-id><pub-id pub-id-type="doi">10.1086/321276</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>JH</given-names></name><name><surname>Gilbert</surname><given-names>JC</given-names></name><name><surname>Tsai</surname><given-names>CT</given-names></name><name><surname>Chiang</surname><given-names>FT</given-names></name><name><surname>Holden</surname><given-names>T</given-names></name><name><surname>Barney</surname><given-names>N</given-names></name><name><surname>White</surname><given-names>BC</given-names></name></person-group><article-title>A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility</article-title><source>J Theor Biol</source><year>2006</year><volume>241</volume><fpage>252</fpage><lpage>261</lpage><pub-id pub-id-type="pmid">16457852</pub-id><pub-id pub-id-type="doi">10.1016/j.jtbi.2005.11.036</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>DQ</given-names></name><name><surname>Whitehead</surname><given-names>PL</given-names></name><name><surname>Menold</surname><given-names>MM</given-names></name><name><surname>Martin</surname><given-names>ER</given-names></name><name><surname>Ashley-Koch</surname><given-names>AE</given-names></name><name><surname>Mei</surname><given-names>H</given-names></name><name><surname>Ritchie</surname><given-names>MD</given-names></name><name><surname>Delong</surname><given-names>GR</given-names></name><name><surname>Abramson</surname><given-names>RK</given-names></name><name><surname>Wright</surname><given-names>HH</given-names></name><name><surname>Cuccaro</surname><given-names>ML</given-names></name><name><surname>Hussman</surname><given-names>JP</given-names></name><name><surname>Gilbert</surname><given-names>JR</given-names></name><name><surname>Pericak-Vance</surname><given-names>MA</given-names></name></person-group><article-title>Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism</article-title><source>Am J Hum Genet</source><year>2005</year><volume>77</volume><fpage>377</fpage><lpage>388</lpage><pub-id pub-id-type="pmid">16080114</pub-id><pub-id pub-id-type="doi">10.1086/433195</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>CH</given-names></name><name><surname>Liang</surname><given-names>KH</given-names></name><name><surname>Hung</surname><given-names>YJ</given-names></name><name><surname>Huang</surname><given-names>LC</given-names></name><name><surname>Pei</surname><given-names>D</given-names></name><name><surname>Liao</surname><given-names>YT</given-names></name><name><surname>Kuo</surname><given-names>SW</given-names></name><name><surname>Bey</surname><given-names>MS</given-names></name><name><surname>Chen</surname><given-names>JL</given-names></name><name><surname>Chen</surname><given-names>EY</given-names></name></person-group><article-title>Analysis of epistasis for diabetic nephropathy among type 2 diabetic patients</article-title><source>Hum Mol Genet</source><year>2006</year><volume>15</volume><fpage>2701</fpage><lpage>2708</lpage><pub-id pub-id-type="pmid">16893912</pub-id><pub-id pub-id-type="doi">10.1093/hmg/ddl203</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>MD</given-names></name><name><surname>Lou</surname><given-names>XY</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name><name><surname>Ma</surname><given-names>JZ</given-names></name><name><surname>Elston</surname><given-names>RC</given-names></name></person-group><article-title>Gene-Gene Interactions Among CHRNA4, CHRNB2, BDNF, and NTRK2 in Nicotine Dependence</article-title><source>Biol Psychiatry</source><year>2008</year><volume>64</volume><fpage>951</fpage><lpage>957</lpage><pub-id pub-id-type="pmid">18534558</pub-id><pub-id pub-id-type="doi">10.1016/j.biopsych.2008.04.026</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Pan</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Feng</surname><given-names>G</given-names></name><name><surname>Fu</surname><given-names>J</given-names></name><name><surname>Bao</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>He</surname><given-names>L</given-names></name></person-group><article-title>An association study of the N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) and NR2B subunit gene (GRIN2B) in schizophrenia with universal DNA microarray</article-title><source>Eur J Hum Genet</source><year>2005</year><volume>13</volume><fpage>807</fpage><lpage>814</lpage><pub-id pub-id-type="pmid">15841096</pub-id><pub-id pub-id-type="doi">10.1038/sj.ejhg.5201418</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yasuno</surname><given-names>K</given-names></name><name><surname>Ando</surname><given-names>S</given-names></name><name><surname>Misumi</surname><given-names>S</given-names></name><name><surname>Makino</surname><given-names>S</given-names></name><name><surname>Kulski</surname><given-names>JK</given-names></name><name><surname>Muratake</surname><given-names>T</given-names></name><name><surname>Kaneko</surname><given-names>N</given-names></name><name><surname>Amagane</surname><given-names>H</given-names></name><name><surname>Someya</surname><given-names>T</given-names></name><name><surname>Inoko</surname><given-names>H</given-names></name><name><surname>Suga</surname><given-names>H</given-names></name><name><surname>Kanemoto</surname><given-names>K</given-names></name><name><surname>Tamiya</surname><given-names>G</given-names></name></person-group><article-title>Synergistic association of mitochondrial uncoupling protein (UCP) genes with schizophrenia</article-title><source>Am J Med Genet B Neuropsychiatr Genet</source><year>2007</year><volume>144B</volume><fpage>250</fpage><lpage>253</lpage><pub-id pub-id-type="pmid">17066476</pub-id><pub-id pub-id-type="doi">10.1002/ajmg.b.30443</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Qin</surname><given-names>S</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Bian</surname><given-names>L</given-names></name><name><surname>Wan</surname><given-names>C</given-names></name><name><surname>Feng</surname><given-names>G</given-names></name><name><surname>Gu</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>He</surname><given-names>G</given-names></name><name><surname>He</surname><given-names>L</given-names></name></person-group><article-title>Systematic study of association of four GABAergic genes: glutamic acid decarboxylase 1 gene, glutamic acid decarboxylase 2 gene, GABA(B) receptor 1 gene and GABA(A) receptor subunit beta2 gene, with schizophrenia using a universal DNA microarray</article-title><source>Schizophr Res</source><year>2007</year><volume>93</volume><fpage>374</fpage><lpage>384</lpage><pub-id pub-id-type="pmid">17412563</pub-id><pub-id pub-id-type="doi">10.1016/j.schres.2007.02.023</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Purcell</surname><given-names>S</given-names></name><name><surname>Neale</surname><given-names>B</given-names></name><name><surname>Todd-Brown</surname><given-names>K</given-names></name><name><surname>Thomas</surname><given-names>L</given-names></name><name><surname>Ferreira</surname><given-names>MA</given-names></name><name><surname>Bender</surname><given-names>D</given-names></name><name><surname>Maller</surname><given-names>J</given-names></name><name><surname>Sklar</surname><given-names>P</given-names></name><name><surname>de Bakker</surname><given-names>PI</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>Sham</surname><given-names>PC</given-names></name></person-group><article-title>PLINK: a tool set for whole-genome association and population-based linkage analyses</article-title><source>Am J Hum Genet</source><year>2007</year><volume>81</volume><fpage>559</fpage><lpage>575</lpage><pub-id pub-id-type="pmid">17701901</pub-id><pub-id pub-id-type="doi">10.1086/519795</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dudbridge</surname><given-names>F</given-names></name></person-group><article-title>Pedigree disequilibrium tests for multilocus haplotypes</article-title><source>Genet Epidemiol</source><year>2003</year><volume>25</volume><fpage>115</fpage><lpage>121</lpage><pub-id pub-id-type="pmid">12916020</pub-id><pub-id pub-id-type="doi">10.1002/gepi.10252</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>YY</given-names></name><name><surname>He</surname><given-names>L</given-names></name></person-group><article-title>SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci</article-title><source>Cell Res</source><year>2005</year><volume>15</volume><fpage>97</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">15740637</pub-id><pub-id pub-id-type="doi">10.1038/sj.cr.7290286</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname><given-names>PJ</given-names></name><name><surname>Law</surname><given-names>AJ</given-names></name></person-group><article-title>Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology</article-title><source>Biol Psychiatry</source><year>2006</year><volume>60</volume><fpage>132</fpage><lpage>140</lpage><pub-id pub-id-type="pmid">16442083</pub-id><pub-id pub-id-type="doi">10.1016/j.biopsych.2005.11.002</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>D</given-names></name><name><surname>He</surname><given-names>L</given-names></name></person-group><article-title>Association study between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia: a meta-analysis</article-title><source>Schizophr Res</source><year>2007</year><volume>96</volume><fpage>112</fpage><lpage>118</lpage><pub-id pub-id-type="pmid">17604607</pub-id><pub-id pub-id-type="doi">10.1016/j.schres.2007.05.017</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname><given-names>PJ</given-names></name><name><surname>Weinberger</surname><given-names>DR</given-names></name></person-group><article-title>Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence</article-title><source>Mol Psychiatry</source><year>2005</year><volume>10</volume><fpage>40</fpage><lpage>685</lpage><pub-id pub-id-type="pmid">15263907</pub-id><pub-id pub-id-type="doi">10.1038/sj.mp.4001558</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ishizuka</surname><given-names>K</given-names></name><name><surname>Paek</surname><given-names>M</given-names></name><name><surname>Kamiya</surname><given-names>A</given-names></name><name><surname>Sawa</surname><given-names>A</given-names></name></person-group><article-title>A review of Disrupted-In-Schizophrenia-1 (DISC1): neurodevelopment, cognition, and mental conditions</article-title><source>Biol Psychiatry</source><year>2006</year><volume>59</volume><fpage>1189</fpage><lpage>1197</lpage><pub-id pub-id-type="pmid">16797264</pub-id><pub-id pub-id-type="doi">10.1016/j.biopsych.2006.03.065</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Detera-Wadleigh</surname><given-names>SD</given-names></name><name><surname>McMahon</surname><given-names>FJ</given-names></name></person-group><article-title>G72/G30 in schizophrenia and bipolar disorder: review and meta-analysis</article-title><source>Biol Psychiatry</source><year>2006</year><volume>60</volume><fpage>106</fpage><lpage>114</lpage><pub-id pub-id-type="pmid">16581030</pub-id><pub-id pub-id-type="doi">10.1016/j.biopsych.2006.01.019</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>D</given-names></name><name><surname>He</surname><given-names>L</given-names></name></person-group><article-title>G72/G30 genes and schizophrenia: a systematic meta-analysis of association studies</article-title><source>Genetics</source><year>2007</year><volume>175</volume><fpage>917</fpage><lpage>922</lpage><pub-id pub-id-type="pmid">17179078</pub-id><pub-id pub-id-type="doi">10.1534/genetics.106.061796</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Badner</surname><given-names>JA</given-names></name><name><surname>Gershon</surname><given-names>ES</given-names></name></person-group><article-title>Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia</article-title><source>Mol Psychiatry</source><year>2002</year><volume>7</volume><fpage>405</fpage><lpage>411</lpage><pub-id pub-id-type="pmid">11986984</pub-id><pub-id pub-id-type="doi">10.1038/sj.mp.4001012</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>CM</given-names></name><name><surname>Levinson</surname><given-names>DF</given-names></name><name><surname>Wise</surname><given-names>LH</given-names></name><name><surname>DeLisi</surname><given-names>LE</given-names></name><name><surname>Straub</surname><given-names>RE</given-names></name><name><surname>Hovatta</surname><given-names>I</given-names></name><name><surname>Williams</surname><given-names>NM</given-names></name><name><surname>Schwab</surname><given-names>SG</given-names></name><name><surname>Pulver</surname><given-names>AE</given-names></name><name><surname>Faraone</surname><given-names>SV</given-names></name><name><surname>Brzustowicz</surname><given-names>LM</given-names></name><name><surname>Kaufmann</surname><given-names>CA</given-names></name><name><surname>Garver</surname><given-names>DL</given-names></name><name><surname>Gurling</surname><given-names>HM</given-names></name><name><surname>Lindholm</surname><given-names>E</given-names></name><name><surname>Coon</surname><given-names>H</given-names></name><name><surname>Moises</surname><given-names>HW</given-names></name><name><surname>Byerley</surname><given-names>W</given-names></name><name><surname>Shaw</surname><given-names>SH</given-names></name><name><surname>Mesen</surname><given-names>A</given-names></name><name><surname>Sherrington</surname><given-names>R</given-names></name><name><surname>O</surname><given-names>NF</given-names></name><name><surname>Walsh</surname><given-names>D</given-names></name><name><surname>Kendler</surname><given-names>KS</given-names></name><name><surname>Ekelund</surname><given-names>J</given-names></name><name><surname>Paunio</surname><given-names>T</given-names></name><name><surname>Lonnqvist</surname><given-names>J</given-names></name><name><surname>Peltonen</surname><given-names>L</given-names></name><name><surname>O</surname><given-names>DM</given-names></name><name><surname>Owen</surname><given-names>MJ</given-names></name><name><surname>Wildenauer</surname><given-names>DB</given-names></name><name><surname>Maier</surname><given-names>W</given-names></name><name><surname>Nestadt</surname><given-names>G</given-names></name><name><surname>Blouin</surname><given-names>JL</given-names></name><name><surname>Antonarakis</surname><given-names>SE</given-names></name><name><surname>Mowry</surname><given-names>BJ</given-names></name><name><surname>Silverman</surname><given-names>JM</given-names></name><name><surname>Crowe</surname><given-names>RR</given-names></name><name><surname>Cloninger</surname><given-names>CR</given-names></name><name><surname>Tsuang</surname><given-names>MT</given-names></name><name><surname>Malaspina</surname><given-names>D</given-names></name><name><surname>Harkavy-Friedman</surname><given-names>JM</given-names></name><name><surname>Svrakic</surname><given-names>DM</given-names></name><name><surname>Bassett</surname><given-names>AS</given-names></name><name><surname>Holcomb</surname><given-names>J</given-names></name><name><surname>Kalsi</surname><given-names>G</given-names></name><name><surname>McQuillin</surname><given-names>A</given-names></name><name><surname>Brynjolfson</surname><given-names>J</given-names></name><name><surname>Sigmundsson</surname><given-names>T</given-names></name><name><surname>Petursson</surname><given-names>H</given-names></name><name><surname>Jazin</surname><given-names>E</given-names></name><name><surname>Zoega</surname><given-names>T</given-names></name><name><surname>Helgason</surname><given-names>T</given-names></name></person-group><article-title>Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia</article-title><source>Am J Hum Genet</source><year>2003</year><volume>73</volume><fpage>34</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">12802786</pub-id><pub-id pub-id-type="doi">10.1086/376549</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choudhury</surname><given-names>K</given-names></name><name><surname>McQuillin</surname><given-names>A</given-names></name><name><surname>Puri</surname><given-names>V</given-names></name><name><surname>Pimm</surname><given-names>J</given-names></name><name><surname>Datta</surname><given-names>S</given-names></name><name><surname>Thirumalai</surname><given-names>S</given-names></name><name><surname>Krasucki</surname><given-names>R</given-names></name><name><surname>Lawrence</surname><given-names>J</given-names></name><name><surname>Bass</surname><given-names>NJ</given-names></name><name><surname>Quested</surname><given-names>D</given-names></name><name><surname>Crombie</surname><given-names>C</given-names></name><name><surname>Fraser</surname><given-names>G</given-names></name><name><surname>Walker</surname><given-names>N</given-names></name><name><surname>Nadeem</surname><given-names>H</given-names></name><name><surname>Johnson</surname><given-names>S</given-names></name><name><surname>Curtis</surname><given-names>D</given-names></name><name><surname>St Clair</surname><given-names>D</given-names></name><name><surname>Gurling</surname><given-names>HM</given-names></name></person-group><article-title>A genetic association study of chromosome 11q22&#x02013;24 in two different samples implicates the FXYD6 gene, encoding phosphohippolin, in susceptibility to schizophrenia</article-title><source>Am J Hum Genet</source><year>2007</year><volume>80</volume><fpage>664</fpage><lpage>672</lpage><pub-id pub-id-type="pmid">17357072</pub-id><pub-id pub-id-type="doi">10.1086/513475</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gurling</surname><given-names>HM</given-names></name><name><surname>Kalsi</surname><given-names>G</given-names></name><name><surname>Brynjolfson</surname><given-names>J</given-names></name><name><surname>Sigmundsson</surname><given-names>T</given-names></name><name><surname>Sherrington</surname><given-names>R</given-names></name><name><surname>Mankoo</surname><given-names>BS</given-names></name><name><surname>Read</surname><given-names>T</given-names></name><name><surname>Murphy</surname><given-names>P</given-names></name><name><surname>Blaveri</surname><given-names>E</given-names></name><name><surname>McQuillin</surname><given-names>A</given-names></name><name><surname>Petursson</surname><given-names>H</given-names></name><name><surname>Curtis</surname><given-names>D</given-names></name></person-group><article-title>Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21&#x02013;22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3&#x02013;24 and 20q12.1-11.23</article-title><source>Am J Hum Genet</source><year>2001</year><volume>68</volume><fpage>661</fpage><lpage>673</lpage><pub-id pub-id-type="pmid">11179014</pub-id><pub-id pub-id-type="doi">10.1086/318788</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>Y</given-names></name><name><surname>Nakamura</surname><given-names>Y</given-names></name><name><surname>Takahashi</surname><given-names>N</given-names></name><name><surname>Saito</surname><given-names>S</given-names></name><name><surname>Aleksic</surname><given-names>B</given-names></name><name><surname>Iwata</surname><given-names>N</given-names></name><name><surname>Inada</surname><given-names>T</given-names></name><name><surname>Ozaki</surname><given-names>N</given-names></name></person-group><article-title>A genetic association study of the FXYD domain containing ion transport regulator 6 (FXYD6) gene, encoding phosphohippolin, in susceptibility to schizophrenia in a Japanese population</article-title><source>Neurosci Lett</source><year>2008</year><volume>438</volume><fpage>70</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">18455306</pub-id><pub-id pub-id-type="doi">10.1016/j.neulet.2008.04.010</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>K</given-names></name><name><surname>Hattori</surname><given-names>E</given-names></name><name><surname>Iwayama</surname><given-names>Y</given-names></name><name><surname>Ohnishi</surname><given-names>T</given-names></name><name><surname>Ohba</surname><given-names>H</given-names></name><name><surname>Toyota</surname><given-names>T</given-names></name><name><surname>Takao</surname><given-names>H</given-names></name><name><surname>Minabe</surname><given-names>Y</given-names></name><name><surname>Nakatani</surname><given-names>N</given-names></name><name><surname>Higuchi</surname><given-names>T</given-names></name><name><surname>Detera-Wadleigh</surname><given-names>SD</given-names></name><name><surname>Yoshikawa</surname><given-names>T</given-names></name></person-group><article-title>Distinguishable haplotype blocks in the HTR3A and HTR3B region in the Japanese reveal evidence of association of HTR3B with female major depression</article-title><source>Biol Psychiatry</source><year>2006</year><volume>60</volume><fpage>192</fpage><lpage>201</lpage><pub-id pub-id-type="pmid">16487942</pub-id><pub-id pub-id-type="doi">10.1016/j.biopsych.2005.11.008</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Glatt</surname><given-names>SJ</given-names></name><name><surname>Faraone</surname><given-names>SV</given-names></name><name><surname>Lasky-Su</surname><given-names>JA</given-names></name><name><surname>Kanazawa</surname><given-names>T</given-names></name><name><surname>Hwu</surname><given-names>HG</given-names></name><name><surname>Tsuang</surname><given-names>MT</given-names></name></person-group><article-title>Family-based association testing strongly implicates DRD2 as a risk gene for schizophrenia in Han Chinese from Taiwan</article-title><source>Mol Psychiatry</source><year>2008</year><pub-id pub-id-type="pmid">18332877</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Glatt</surname><given-names>SJ</given-names></name><name><surname>Faraone</surname><given-names>SV</given-names></name><name><surname>Tsuang</surname><given-names>MT</given-names></name></person-group><article-title>Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia</article-title><source>Mol Psychiatry</source><year>2003</year><volume>8</volume><fpage>911</fpage><lpage>915</lpage><pub-id pub-id-type="pmid">14593428</pub-id><pub-id pub-id-type="doi">10.1038/sj.mp.4001321</pub-id></citation></ref><ref id="B39"><citation citation-type="other"><article-title>F-SNP</article-title><ext-link ext-link-type="uri" xlink:href="http://compbio.cs.queensu.ca/F-SNP/"/></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thornton-Wells</surname><given-names>TA</given-names></name><name><surname>Moore</surname><given-names>JH</given-names></name><name><surname>Haines</surname><given-names>JL</given-names></name></person-group><article-title>Genetics, statistics and human disease: analytical retooling for complexity</article-title><source>Trends Genet</source><year>2004</year><volume>20</volume><fpage>640</fpage><lpage>647</lpage><pub-id pub-id-type="pmid">15522460</pub-id><pub-id pub-id-type="doi">10.1016/j.tig.2004.09.007</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Culverhouse</surname><given-names>R</given-names></name><name><surname>Suarez</surname><given-names>BK</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Reich</surname><given-names>T</given-names></name></person-group><article-title>A perspective on epistasis: limits of models displaying no main effect</article-title><source>Am J Hum Genet</source><year>2002</year><volume>70</volume><fpage>461</fpage><lpage>471</lpage><pub-id pub-id-type="pmid">11791213</pub-id><pub-id pub-id-type="doi">10.1086/338759</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dupont</surname><given-names>WD</given-names></name><name><surname>Plummer</surname><given-names>WD</given-names></name></person-group><article-title>Power and sample size calculations for studies involving linear regression</article-title><source>Control Clin Trials</source><year>1998</year><volume>19</volume><fpage>589</fpage><lpage>601</lpage><pub-id pub-id-type="pmid">9875838</pub-id><pub-id pub-id-type="doi">10.1016/S0197-2456(98)00037-3</pub-id></citation></ref></ref-list></back></article> 